...es its name from its first known site of origin, t... bound to anti-chymotrypsin (PSA-ACT) and other co... in patients with prostate cancer, benign prostati...tion, PSA serum levels appear to correlate with th...
Increase profitability by reducing chair time with simple test,sequences that can be administered by ancillary office staff in,less than 5 minutes. New Unsurpassed Homogenous Illumination.,Back
Contrast Sensitivity is Recognized as a Valuable Tool for Measuring Functional Vision Loss Caused by Early Eye Disease. Near Test F.A.C.T. 101: Size 5 in x 7 in (12.7cm x 17.78cm) Can be Hand-Held or
Adult: Letter Monocular Acuity, Binocular Astigmatism, Acuity Balance, Supression, Binocular Acuity, Fixation Desparity, Muscle Balance, Stereopsis
Medicine Products:(Date:12/2/2008)...wire/ -- Research scientists using a,novel, hand-...have found that,chronic stroke patients can be re... at the annual meeting of the Radiological Society... using fMRI to map the brain in order to track,st...the brain has the ability to regain function throu...
(Date:12/2/2008)...e/ -- Today, the University HealthSystem,Consorti... been appointed Vice,President, Quality and Patie...,a year and a half as director of quality and infe...n Chicago, Ill. Previously, she was the senior di.... , "Julie,s experience at Northwestern has...
(Date:12/2/2008)...e-USNewswire/ -- A scientist who helped,explain h...s of information we,see has won the 2009 Univers.... , Anne Treisman, the James S. McDonnell Disti...rinceton University , was selected for the ninth G...ons. , Treisman, a cognitive psychologist, ...
(Date:12/2/2008)...ries have substantially higher rates of mental hea...g to results from a systematic review and meta-ana...Searching for studies over the past four decades c...rs in homeless people, Seena Fazel and colleagues ...involving 5,684 homeless individuals based in the ...
Breaking Medicine News(10 mins):Health News:Robotic Technology Improves Stroke Rehabilitation 2Health News:Robotic Technology Improves Stroke Rehabilitation 3Health News:Julie Cerese Returns to University HealthSystem Consortium as Vice President of Quality and Patient Safety 2Health News:Theory of How Brain Builds Images Earns Grawemeyer Prize 2(Date:12/1/2008)...ated With ENB-0040 at Children,s Hospital, Health ...ec. 1 Enobia Pharma, an emerging C...l therapeutics for serious bone disorders, today a...ical program for hypophosphatasia was dosed. Enobi...) with ENB-0040 for the treatment of this rare and...
(Date:12/1/2008)...policy , , ROCHESTER, Minn., Dec. 1 /PRNew...finds the use of the drug therapy etanercept ineff...nflammation of the liver caused by excessive consu...blished in the December issue of Gastroenterology...IDEO ALERT: Additional audio and video resources, ...
(Date:12/1/2008)... Following a,Request for...e an MVA-based,third generation smallpox vaccine... behalf of the Canadian Department of National Def...or the delivery of IMVAMUNE(R). , The Canad...of the,country,s bio-preparedness programme. , ...
(Date:12/1/2008)...ll/ -- GeoVax Labs, Inc.,(OTC Bulletin Board: GOV...ing,human vaccines for diseases caused by HIV-1 (...s agents, announced today that the launch of its P...welve sites across North and South America.,These...tional Institutes of,Health (NIH), and the HIV Va...
Breaking Medicine Technology:Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 2Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 5Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 2Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 3The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 2The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 3GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 2GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 3Consumer Reports Poll 3A Americans Demand Health Reform But Are Unsure About How to Achieve it 11025 1Consumer Reports Poll 3A Americans Demand Health Reform But Are Unsure About How to Achieve it 11025 2Consumer Reports Poll 3A Americans Demand Health Reform But Are Unsure About How to Achieve it 11025 3Consumer Reports Poll 3A Americans Demand Health Reform But Are Unsure About How to Achieve it 11025 4Halogen Receives High Ratings from Bersin 26 Associates Company recognized as a market leader and receives praise for outstanding customer satisfa 3031 1Halogen Receives High Ratings from Bersin 26 Associates Company recognized as a market leader and receives praise for outstanding customer satisfa 3031 2Stevens researchers provide oversight for three year mariculture program in Egypt and Israel 2118 1West Pharmaceutical Services to Present at the 2008 UBS Global Healthcare Services Conference 11019 1West Pharmaceutical Services to Present at the 2008 UBS Global Healthcare Services Conference 11019 2..., Australia, May 03, 2007 /PRNewswire-FirstCall/ -... that the Company,intends to initiate a Phase 1b c...ty of the improved formulation of its transdermal,...cting insulin.,The trial is expected to commence i... is being developed as a novel "needle-free",way o...
...ER, N.J., May 03, 2007 /PRNewswire-FirstCall/ --,A...utical company,through its Pharmaceuticals Divisio...acokinetic study of its investigational,abuse-dete...scientific meeting of the American Pain Society in...e characteristics of this,extended-release morphin...
Other Medicine Technology:Phosphagenics to Commence Phase 1b Transdermal Insulin Clinical,Trial in Second Quarter 2Alpharma Presents Positive Pharmacokinetic Study Results of Its,Investigational Abuse-Deterrent, Extended-Release Opioid 2Alpharma Presents Positive Pharmacokinetic Study Results of Its,Investigational Abuse-Deterrent, Extended-Release Opioid 3Alpharma Presents Positive Pharmacokinetic Study Results of Its,Investigational Abuse-Deterrent, Extended-Release Opioid 4